CNS relapse of diffuse large B cell Lymphoma: a single centre experience

ABSTRACT

Background and Objective: Central nervous system [CNS] relapse of diffuse large B cell lymphoma [DLBCL] is relatively uncommon and nearly fatal. Two years CNS relapse risk is 0.8% in low, 3.9% in intermediate and 12 % in high risk patients. Our aim was to study, the baseline characteristics and outcome in term of median survival of DLBCL patients with CNS relapse